HOME | PRESS RELEASES | HOW TO ORDER | CONTACT US | CAREERS | Japanese

 

Recently Published

Modeling and Simulation to
Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects, in Clinical Pharmacology & Therapeutics.

Read Online Abstract

Upcoming Events


Pharsight to present on oncology modeling at ASCPT, as part of session on "Should We Tolerate the Maximally Tolerated Dose for Targeted Anti-Cancer Agents?”

View Details & ASCPT Posters

Pharsight software products and services facilitate improved productivity and strategic decision making in drug development. Since the company’s founding in 1995, our goal remains to help customers reduce the time, cost and risk of drug development. With more than 1200 customers worldwide, Pharsight products and services are used by all of the world’s top 50 drug development organizations. Pharsight software improves the value and availability of preclinical and clinical program data for PK/PD modeling, analysis, data management, and reporting. Pharsight Consulting Services is the world’s largest and most experienced pharmacometric consulting group, a global team of experts dedicated to supporting strategic development decisions and submission-ready analyses for new drug approval.